Barclays
THTX

Barclays’s Theratechnologies THTX Stock Holding History

Barclays’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-400
Closed -$944 – 5731
2025
Q2 		$944 Buy
+400
New +$980 ﹤0.01% 5063

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $1.9B AUM 24.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $854M AUM 15.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Barclays's THTX Position: Q3 2025 in Review

Barclays sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 400 shares — an estimated $944 sold.

Barclays first reported a position in THTX in Q2 2025 and held it in 1 quarter. The position peaked at $944 in Q2 2025. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Barclays reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Barclays sold 400 Theratechnologies shares in Q3 2025, an estimated $944.
  • Barclays first reported a position in Theratechnologies in Q2 2025 and held it in 1 quarter.
  • Barclays's Theratechnologies position peaked at $944 in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.